There have been 50 recent insider transactions recorded for Atea Pharmaceuticals, Inc. (AVIR), including 17 buys and 31 sells. Total insider buying was valued at $1.21M and total insider selling at $2.16M.
Notable insiders with recent activity include Corcoran Andrea, Sommadossi Jean-pierre, Foster Wayne. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — AVIR
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-11 |
Corcoran Andrea |
See Remarks |
Option Exercise |
60,000 |
$1.24 |
$74.4K |
- |
| 2026-02-03 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Option Exercise (Sell) |
300,000 |
$1.24 |
$372K |
- |
| 2026-01-31 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Option Exercise (Sell) |
99,517 |
- |
- |
- |
| 2026-01-31 |
Corcoran Andrea |
See Remarks |
Option Exercise (Sell) |
10,500 |
- |
- |
- |
| 2026-01-31 |
Foster Wayne |
EVP, Chief Accounting Officer |
Option Exercise (Sell) |
8,000 |
- |
- |
- |
| 2026-01-31 |
Horga Maria Arantxa |
Chief Medical Officer |
Option Exercise (Sell) |
9,750 |
- |
- |
- |
| 2026-01-31 |
Vavricka John |
Chief Commercial Officer |
Option Exercise (Sell) |
8,750 |
- |
- |
- |
| 2026-01-31 |
Hammond Janet Mj |
Chief Development Officer |
Option Exercise (Sell) |
11,250 |
- |
- |
- |
| 2025-06-20 |
Berger Franklin M |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Duncan Barbara Gayle |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Polsky Bruce |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Murphy Polly A. |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Lucidi Bruno |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Adams Jerome M. |
Director |
Option Exercise (Sell) |
29,600 |
- |
- |
- |
| 2025-06-20 |
Berman Howard |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-06-20 |
Berman Howard |
Director |
RSU Award |
164,800 |
$3.25 |
$535.6K |
164,800 |
| 2025-02-20 |
Kirsch Arthur S |
Director |
Unknown |
- |
- |
- |
10,000 |
| 2025-02-20 |
Kirsch Arthur S |
Director |
RSU Award |
164,800 |
$3.14 |
$517.47K |
164,800 |
| 2025-01-31 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
RSU Award |
99,518 |
- |
- |
99,518 |
| 2025-01-31 |
Corcoran Andrea |
See Remarks |
RSU Award |
10,500 |
- |
- |
10,500 |
| 2025-01-31 |
Foster Wayne |
EVP, Chief Accounting Officer |
RSU Award |
8,000 |
- |
- |
8,000 |
| 2025-01-31 |
Horga Maria Arantxa |
Chief Medical Officer |
RSU Award |
9,750 |
- |
- |
9,750 |
| 2025-01-31 |
Vavricka John |
Chief Commercial Officer |
RSU Award |
8,750 |
- |
- |
8,750 |
| 2025-01-31 |
Hammond Janet Mj |
Chief Development Officer |
RSU Award |
11,250 |
- |
- |
11,250 |
| 2025-01-16 |
Berger Franklin M |
Director |
Informative Sell |
10,000 |
$3.36 |
$33.61K |
476,897 |
| 2025-01-16 |
Berger Franklin M |
Director |
Informative Buy |
10,000 |
$3.36 |
$33.61K |
476,897 |
| 2025-01-15 |
Berger Franklin M |
Director |
Informative Sell |
15,000 |
$3.19 |
$47.88K |
466,897 |
| 2025-01-15 |
Berger Franklin M |
Director |
Informative Buy |
15,000 |
$3.19 |
$47.88K |
466,897 |
| 2024-12-10 |
Berger Franklin M |
Director |
Informative Sell |
359,606 |
$2.85 |
$1.02M |
451,897 |
| 2024-09-19 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Informative Sell |
1,841 |
$4.00 |
$7.37K |
5,866,025 |
| 2024-09-18 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Informative Sell |
22,187 |
$4.03 |
$89.47K |
5,867,866 |
| 2024-09-17 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Informative Sell |
33,941 |
$4.05 |
$137.32K |
5,890,053 |
| 2024-06-21 |
Berger Franklin M |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-21 |
Duncan Barbara Gayle |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-21 |
Polsky Bruce |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-21 |
Murphy Polly A. |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-21 |
Lucidi Bruno |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-21 |
Adams Jerome M. |
Director |
RSU Award |
29,600 |
- |
- |
29,600 |
| 2024-06-20 |
Polsky Bruce |
Director |
Informative Sell |
17,544 |
$3.49 |
$61.14K |
65,606 |
| 2024-06-16 |
Berger Franklin M |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-16 |
Duncan Barbara Gayle |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-16 |
Polsky Bruce |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-16 |
Murphy Polly A. |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-16 |
Lucidi Bruno |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-16 |
Adams Jerome M. |
Director |
Option Exercise (Sell) |
33,150 |
- |
- |
- |
| 2024-06-05 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Informative Sell |
1,006 |
$4.00 |
$4.02K |
5,923,994 |
| 2024-02-01 |
Sommadossi Jean-pierre |
President, CEO, and Chairman |
Informative Sell |
56,910 |
$3.85 |
$218.82K |
116,557 |
| 2024-02-01 |
Corcoran Andrea |
See Remarks |
Informative Sell |
15,843 |
$3.84 |
$60.91K |
670,208 |
| 2024-02-01 |
Foster Wayne |
EVP, Chief Accounting Officer |
Informative Sell |
12,477 |
$3.84 |
$47.9K |
20,857 |
| 2024-02-01 |
Horga Maria Arantxa |
Chief Medical Officer |
Informative Sell |
15,870 |
$3.84 |
$60.96K |
25,664 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
